chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 8 hours after the 2nd shot I developed Severe dizziness. Went to bed. Laid down for about 1/2 hr, When got up to go to bathroom, my body shook ALL OVER all over: legs, hands, arms ---extreme shaking. Very hard to walk to bathroom. Even when sat down to urinate, body still shook all over. Hard to go back to bed--still shaking--held on to doors, furniture. Slept all night until 9am the next morning. Stayed in bed for another hr. Got up, but then back to bed for most of the day. Got up at 7pm---ate hot oatmeal.. Back to bed about 9pm. Today, 2 days after shot, was able to stay up most of the day. Slept from 2:30pm until 4pm. Then ate some pizza. Had no interest in eating even when I ate the pizza (did not feel nauseous, just no interest)
Feel dizzy and ears ringing. transported to medic area in wheelchair, talkative. stay in observation for 30 minutes and went home on her own.
The patient states that, "I have experienced persistent bilateral foot problem of unclear etiology since Feb of 2000. I do not recall the exact date of my flu shot, but I believe that I received a flu vaccine, through my employee health office, about 1-3 weeks prior to the onset of my symptoms. I have attempted to obtain the exact date of inoculation through my employer. However, the employee health and medical records staff are unable to provide me with documentation re:date of my flu shot. I have seen many physicians/specialists and have undergone many diagnostic tests in the past 2 years. Many diseases, such as multiple sclerosis, several types of neuropathies, Lyme diseases, autoimmune diseases, etc.., have been ruled out through diagnostic tests, including foot/ankle/brain/spine MRIs, x-rays, and blood tests. I still do not have a clear diagnosis. Many physicians have suggested that my symptoms and subsequent physical limitations may be related to a virus, but it is only in the recent month that a "new" neurologist has recommended that I formally file a VAERS form. My symptoms are localized to the bottoms of both of my feet. Prior to pain management with medication, I experienced extremely severe hot knife-stabbing pain, which restricted my ability to tolerate standing (even for 5 mins) or walking. I also experienced paresthesias/numbness even when I was not weighbearing. I also lost motor function of 2 of my toes and developed ankle weakness. I have been severely limited in function since onset of these symptoms. I was essentially housebond the first 3 months of these symptoms. I was gradually able to tolerate more walking once I started taking neurontin and with the use of crutches (which allowed me to walk maybe 200 ft before my symptoms would increase). After about one year, I was finally able to walk very short distances (and not on a daily basis) with a cane. Presently, my walking and standing tolerance is still very limited as compared to my previously active lifestyle. Because of unclear etiology of my symptoms, I have essentially been "medically managed" with medication. Throughout the last 2 years, I have continued to make very slow progress in terms of increased walking/standing tolerance, and my physicians are unable to offer clear explanations for the onset of symptoms and my "natural" progress in the absence of a clear diagnosis and treatment plan. As mentioned above, some of these physician have suggested a "viral" cause. I have attempted to provide you with a brief description of my situation." per  doc #213154, 60 day follow-up, incomplete, but continuing recovery from foot pain, loss of left 4th and 5th toes, ankle weakness.
Thursday Jan 25 had a pneumococcal vaccine around 6pm. By 1pm next day had developed a high fever (102.6). By 2:15pm started to have a febrile seizure. Lasted about a couple of minutes. Was rushed to ER by ambulance. Checked out at hospital to find the beginnings of an ear infection. The beginnings of the ear infection and the immunization together may have caused a high fever then caused the febrile seizure. Was discharged from ER 8:30pm Friday night. Not admitted to hospital.
Approximately 15 hours after injection, was awoken with very severe chills and incontrollable shaking. Was so cold, had to get a heating blanket to put over me, along with 2 blankets. Was shaking so bad, could hardly walk. Was slightly disoriented at the time. This lasted for 4 hours. Temperature is normally 95.6, did rise to 98.7. Had severe body aches that lasted until the next day, but were not as severe. the following day was very tired and muscles were achy. I did take tylenol, which seemed to help.
Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; Vaccine administered to patient past its 30 day expiry date; Patient received 0.3 mL dose as booster dose of Moderna Covid-19 vaccine; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered to patient past its 30 day expiry date), OVERDOSE (Patient received 0.3 mL dose as booster dose of Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2022 at 4:32 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .3 milliliter. On 13-Mar-2022 at 4:32 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to patient past its 30 day expiry date) and OVERDOSE (Patient received 0.3 mL dose as booster dose of Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered to patient past its 30 day expiry date), OVERDOSE (Patient received 0.3 mL dose as booster dose of Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. On 13-Mar-2022, the patient received the booster dose of the vaccine. No treatment information was reported.   This case was linked to MOD-2022-542869 (Patient Link).
Got swelling on the right side of my face.; Pregnant now 38 weeks.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 28-years-old pregnant female patient received BNT162B2 (Solution for injection, Lot number: EW0187), via an unknown route of administration in right arm on 22Sep2021 (at the age of 28-years-old) as dose number unknown, single for COVID-19 immunization at pharmacy and received other vaccine on same date was influenza vaccine (FLU VACCINE) in right arm on 22Sep2021 as dose number unknown, single. The patient's medical history included vaso vagal syncope and allergic to Latex. She had 38 weeks of prospective pregnancy. Due date was 01Oct2021. Concomitant medication was not reported. On 22Sep2021, the patient experienced got swelling on the right side of her face. Non-serious case. Event resulted in emergency room/department or urgent care. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. No treatment for event. The outcome of the event was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Dizziness (feeling off-balance when walking) and some weakness Pfizer-BioNTech COVID-19 Vaccine EUA
Administer expired vaccine to 450 patients after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients after the manufacture date of expiration) in a 74-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A`) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live Follow up contains Non significant information.
Fever of 102 at 10:30 pm; chills; fatigue.   I had C19? in early Nov 2020 and was in hospital from Nov 19-22, 2020
High fever, severe flu like symptoms, complete loss of taste and smell, being treated for severe sinusitis. Diarrhea, nausea.  I have had covid before-these symptoms have been worse than when I had covid.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Patient experienced syncopal episode within 5 minutes of administration of second dosage of Moderna Covid-19 vaccination, patient was unconscious less than 30 seconds, spontaneously awoken, and was fully recovered within 15 minutes.
I exp. really bad cold symptoms, fatigue, sinus pressure will worsen and  then gets better with elevating fever over a 10 day period. My left arm had swollen up twice the size of normal lasting to 7/30/2021. I have been sick since Dose 2 won't go away still exp the same symptoms feels like some days I have flu, some days I have bad allergies and constantly moves between those stages. I haven't went anywhere and some days get my son to school(have to ask his father to pick him up) since the vaccine I have been so sick.
felt very lethargic; started feeling tingling of tongue, face and neck immediately and it is still there; face has burning sensation; fatigue; she had abdominal discomfort; nausea; felt as if she was going to faint right away; diarrhea; patient became red,; Patient started with blurred vision in her left eye 2 days later; her tongue went numb; her heartrate accelerated (115 pulse); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (patient became red,), ABDOMINAL DISCOMFORT (she had abdominal discomfort), VISION BLURRED (Patient started with blurred vision in her left eye 2 days later), HYPOAESTHESIA ORAL (her tongue went numb) and HEART RATE INCREASED (her heartrate accelerated (115 pulse)) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VISION BLURRED (Patient started with blurred vision in her left eye 2 days later), HYPOAESTHESIA ORAL (her tongue went numb) and HEART RATE INCREASED (her heartrate accelerated (115 pulse)). On 03-Mar-2021, the patient experienced ERYTHEMA (patient became red,), PRESYNCOPE (felt as if she was going to faint right away), DIARRHOEA (diarrhea) and NAUSEA (nausea). On 04-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (she had abdominal discomfort). On an unknown date, the patient experienced LETHARGY (felt very lethargic), PARAESTHESIA ORAL (started feeling tingling of tongue, face and neck immediately and it is still there), BURNING SENSATION (face has burning sensation) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) (intramuscular) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) (intramuscular) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (patient became red,), ABDOMINAL DISCOMFORT (she had abdominal discomfort), VISION BLURRED (Patient started with blurred vision in her left eye 2 days later), HYPOAESTHESIA ORAL (her tongue went numb), HEART RATE INCREASED (her heartrate accelerated (115 pulse)), PRESYNCOPE (felt as if she was going to faint right away), DIARRHOEA (diarrhea), LETHARGY (felt very lethargic), PARAESTHESIA ORAL (started feeling tingling of tongue, face and neck immediately and it is still there), BURNING SENSATION (face has burning sensation), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non significant follow up. Adverse event contact information was updated
zapped of energy; chilled; body aches; mild sore throat; slept about 15 hours; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EN5318), via an unspecified route of administration single dose arm left on 29Jan2021 09:00 (at the age of 58) for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced zapped of energy on 31Jan2021 16:00, chilled on 31Jan2021 16:00, body aches on 31Jan2021 16:00, mild sore throat on 31Jan2021 16:00, slept about 15 hours on 31Jan2021 16:00. No treatment administered. The events outcome was recovered.
This case was reported by a pharmacist via sales rep and described the occurrence of ear pain in a 81-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on 25th May 2018). On 11th September 2018, the patient received the 2nd dose of SHINGRIX. In September 2018, less than a week after receiving SHINGRIX, the patient experienced ear pain, dry mouth and balance difficulty. On an unknown date, the outcome of the ear pain, dry mouth and balance difficulty were unknown. It was unknown if the reporter considered the ear pain, dry mouth and balance difficulty to be related to SHINGRIX. Additional details were reported as follows: On 22nd May 2017, the patient's Glycosylated hemoglobin (A1C) was 7.1. On 30th January 2018, the patient's A1C was 6.9. In 2018, the patient A1C was elevated to 13.7. On 17th September 2018, the patient reported to primary care physician (PCP) with ear pain, dry mouth and poor balance. Nothing else was new in the patient's medical chart between previous A1C and elevated A1C except SHINGRIX. The reporter was agree to follow up from GlaxoSmithKline.
Information has been received from a medical assistant concerning an approximately 26 year old female who in the early 1970s was vaccinated with the first dose of MMR II (lot number not reported). In 1990, the patient had her titers drawn and was shown to have no immunity to mumps. The patient received a second dose of MMR II (lot number not reported) in early 1992. In 2008, she had her titers drawn again and was shown to have no immunity to measles, mumps or rubella. In the late summer of 2008, the patient received a third dose of MMR II (lot number not reported) because of her lack of immunity. The patient had sought unspecified medical attention. Additional information has been requested.
Redness, swelling, firm lump, and pain at vaccine site in left thigh.  Diameter of lump approx 4 cm.  Onset within 24 hours, worsening over 1-2 days, and gradual improvement over 1-2 days so far.  Lump still present
Injection was really achy; Headache; mild nausea; felt warm; Fever; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th September 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 25th September 2020, 8 hrs after receiving Shingrix, the patient experienced injection site pain, headache, nausea, feeling of warmth and fever. On 26th September 2020, the outcome of the injection site pain, headache, nausea, feeling of warmth and fever were recovered/resolved.   It was unknown if the reporter considered the injection site pain, headache, nausea, feeling of warmth and fever to be related to Shingrix.  Additional details were provided as follows: The case was reported by consumer herself. The patient received Shingrix in her left deltoid and reported various reactions.  Eight hours later consumer reported the injection was really achy, then developed a headache, mild nausea, felt warm, and then went to bed due to symptoms.  Consumer reported all symptoms resolved within 24 hours.  Consumer was concerned due to not feeling robust and awful side effects as experienced with 1st dose of Shingrix.  The reporter consented to follow up. The case had been linked with US2020AMR239281 2nd dose of patient, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR239281:same reporter, Same Patient
Approximately 5 min after recieving shot L arm was sore from injection site to wrist. Pt states it is a steady soreness that has not dissipated over past 3 weeks. Soreness is present constantly but increases when abducting and adducting arm, picking up objects with arm. Pt came in to military clinic today 02/19/10 to see MD referral to Rheumatoligist and Vaers report.
pt says she started feeling very fatigued, nauseated with chills and abdominal cramps.  She has hot flashes and then gets very cold.  On 5/19/21  she continues to have all of these symptoms and will contact her PCP for medical treatment.
Fever (up to 101.9), dizziness, nausea, fatigue, muscle pain, severe headache.
Approx. 10 hrs. after MMR vax, pt. awoke crying, hallucinating (seeing snakes on his bed sheet), also had fever.
Injection site was very sore; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR151190   Additional Information: GSK Receipt Date: 19-OCT-2022 Reporter's Comment: The reporter stated that a patient got her first Shingrix vaccine sometime in July 2022 in left arm.   The reporter stated that after her shot, the injection site was very sore for a few days and it was now resolved.   The reporter gave consent to follow up. For tolerance to the 2nd dose refer case US2022AMR151190.; Sender's Comments:  US-GSK-US2022AMR151190:Same reporter
That night after vaccine, I became really dizzy and fell in my bathroom landing in the tub. I didn't pass out, but I did suffer from Vertigo and a Migraine for a couple of days. I wasn't able to reach my PCP so I went to the ER as it still hadn't passed. At the ER I was given a CT scan and was started on Meclizine, I took it for 2 days and the dizzyness and headache subsided. I was asked to check back in with my PCP, from there I was referred to an ENT. After that appt I was referred to a Vestibular Therapist. I'm still waiting to hear back to make that appt.
Uterine bleeding at cycle day 10; no history of early menstrual periods or bleeding with ovulation.
2wks & 2 days p/vax pt was very SOB, rapid heart beat & couldn't breath-called 911 who gave breathing tx & took to hosp; pt was staring & very pale; was shaking & trembling;
Unable to sleep; second shot on 09 JUL 2020; red bumps that look like mosquito bites; red bumps that look like mosquito bites /  bumps are red and itchy; This case was reported by a consumer and described the occurrence of red rash in a 89-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included prednisone for local swelling and itchy rash.   Previously administered products included Shingrix (1st dose received in May 2018).   On 9th July 2020, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, the patient started prednisone at an unknown dose and frequency. On 9th July 2020, immediately after receiving Shingrix, the patient experienced red rash, itchy rash and drug dose administration interval too long. On an unknown date, the patient experienced sleeplessness. The patient was treated with steroid cream. The action taken with prednisone was unknown. On an unknown date, the outcome of the red rash and itchy rash were not recovered/not resolved and the outcome of the sleeplessness and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the red rash and itchy rash to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient's spouse. The patient received 2nd dose later than the recommended interval, which led to lengthening of vaccination schedule. The patient received Shingrix dose in left arm. The reporter did not have batch number or expiry date but did have prescription (rx) number, it was 1741250. Immediately after the shot, the patient developed red bumps that look like mosquito bites. The bumps spread to his other arm and on his back. The bumps were red and itchy and he scratches until it bleeds. The patient seen a dermatologist and had tried prednisone by mouth and steroidal creams. The Prednisone made him unable to sleep. The bumps started right after the injection in July and have not resolved till the time of reporting. The reporter consented to follow up. It was unknown if the reporter considered the sleeplessness to be related to Prednisone. This case has been linked to US2021001354 and US2021001358, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021001354:same reporter US-GLAXOSMITHKLINE-US2021001358:same reporter
This spontaneous report was received from a health professional via company representative refers to a 53 year old female patient. The patients medical history included an episode of shingles about twelve years ago. On an unknown date in NOV-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date and route was not reported). No concomitant medications reported. ON an unknown date in NOV-2012, the patient stated that one day after receiving ZOSTAVAX, the patient developed soreness and redness around the injection site. The next day the redness around the injection site spread to about 4 inches in diameter. Additionally the patient developed three blisters that did not open. On the fourth day, the patient experienced severe burning and itching around the injection site that extended down to the elbow. By the fifth day after receiving ZOSTAVAX, the adverse symptoms disappeared. There was no lab diagnostics performed. There was no treatment rendered for the events. The outcome of the reported events were recovered at the time of this report. The patient did not seek medical attention. Additional information is not expected.